was read the article
array:21 [ "pii" => "X2013251411000227" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Sep.11122" "estado" => "S300" "fechaPublicacion" => "2011-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:683-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5575 "formatos" => array:3 [ "EPUB" => 288 "HTML" => 4577 "PDF" => 710 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X021169951100022X" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Sep.11122" "estado" => "S300" "fechaPublicacion" => "2011-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2011;31:683-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7222 "formatos" => array:3 [ "EPUB" => 298 "HTML" => 6344 "PDF" => 580 ] ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Sistema Ultracontrol® en la clínica diaria de la hemodiafiltración en línea posdilucional: volumen de infusión alcanzado y aplicabilidad con distintos dializadores" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "683" "paginaFinal" => "689" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical application of Ultracontrol®: infusion volume and use with different dialyzers" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_108_20440_es_11122_an1.jpg" "Alto" => 279 "Ancho" => 600 "Tamanyo" => 155474 ] ] "descripcion" => array:1 [ "es" => "Siglas y definiciones" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Albalate Ramón, M. Albalate Ramón, Rafael Perez Garcia, R. Perez Garcia, Patricia de Sequera Ortiz, P. de Sequera Ortiz, Roberto Alcázar Arroyo, R. Alcázar Arroyo, Elena Corchete Prats, E. Corchete Prats, Marta Puerta Carretero, M. Puerta Carretero, Mayra Ortega Díaz, M. Ortega Díaz, Alexia Mosse, A. Mosse" "autores" => array:16 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Albalate Ramón" ] 1 => array:2 [ "Iniciales" => "M." "apellidos" => "Albalate Ramón" ] 2 => array:2 [ "nombre" => "Rafael" "apellidos" => "Perez Garcia" ] 3 => array:2 [ "Iniciales" => "R." "apellidos" => "Perez Garcia" ] 4 => array:2 [ "nombre" => "Patricia" "apellidos" => "de Sequera Ortiz" ] 5 => array:2 [ "Iniciales" => "P." "apellidos" => "de Sequera Ortiz" ] 6 => array:2 [ "nombre" => "Roberto" "apellidos" => "Alcázar Arroyo" ] 7 => array:2 [ "Iniciales" => "R." "apellidos" => "Alcázar Arroyo" ] 8 => array:2 [ "nombre" => "Elena" "apellidos" => "Corchete Prats" ] 9 => array:2 [ "Iniciales" => "E." "apellidos" => "Corchete Prats" ] 10 => array:2 [ "nombre" => "Marta" "apellidos" => "Puerta Carretero" ] 11 => array:2 [ "Iniciales" => "M." "apellidos" => "Puerta Carretero" ] 12 => array:2 [ "nombre" => "Mayra" "apellidos" => "Ortega Díaz" ] 13 => array:2 [ "Iniciales" => "M." "apellidos" => "Ortega Díaz" ] 14 => array:2 [ "nombre" => "Alexia" "apellidos" => "Mosse" ] 15 => array:2 [ "Iniciales" => "A." "apellidos" => "Mosse" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251411000227" "doi" => "10.3265/Nefrologia.pre2011.Sep.11122" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411000227?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169951100022X?idApp=UINPBA000064" "url" => "/02116995/0000003100000006/v0_201502091400/X021169951100022X/v0_201502091400/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251411000219" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Aug.10973" "estado" => "S300" "fechaPublicacion" => "2011-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:690-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 15142 "formatos" => array:3 [ "EPUB" => 307 "HTML" => 13365 "PDF" => 1470 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "690" "paginaFinal" => "696" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Validación del cuestionario simplificado de adherencia a la medicación (SMAQ) en pacientes con trasplante renal en terapia con tacrolimus" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10973_108_23949_en_10973t1.jpg" "Alto" => 279 "Ancho" => 600 "Tamanyo" => 145872 ] ] "descripcion" => array:1 [ "en" => "Socio-demographic variables" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => " Grupo estudio VATREN, Grupo de Estudio VATREN, Francisco José Ortega Suárez, F.J. Ortega Suárez, Jaime Sánchez Plumed, J. Sánchez Plumed, Miguel Ángel Pérez Valentín, M.A. Pérez Valentín, Porfirio Pereira Palomo, P. Pereira Palomo, Miguel Ángel Muñoz Cepeda, M.A. Muñoz Cepeda, Dolores Lorenzo Aguiar, D. Lorenzo Aguiar" "autores" => array:14 [ 0 => array:1 [ "apellidos" => "Grupo estudio VATREN" ] 1 => array:1 [ "apellidos" => "Grupo de Estudio VATREN" ] 2 => array:2 [ "nombre" => "Francisco José" "apellidos" => "Ortega Suárez" ] 3 => array:2 [ "Iniciales" => "F.J." "apellidos" => "Ortega Suárez" ] 4 => array:2 [ "nombre" => "Jaime" "apellidos" => "Sánchez Plumed" ] 5 => array:2 [ "Iniciales" => "J." "apellidos" => "Sánchez Plumed" ] 6 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Pérez Valentín" ] 7 => array:2 [ "Iniciales" => "M.A." "apellidos" => "Pérez Valentín" ] 8 => array:2 [ "nombre" => "Porfirio" "apellidos" => "Pereira Palomo" ] 9 => array:2 [ "Iniciales" => "P." "apellidos" => "Pereira Palomo" ] 10 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Muñoz Cepeda" ] 11 => array:2 [ "Iniciales" => "M.A." "apellidos" => "Muñoz Cepeda" ] 12 => array:2 [ "nombre" => "Dolores" "apellidos" => "Lorenzo Aguiar" ] 13 => array:2 [ "Iniciales" => "D." "apellidos" => "Lorenzo Aguiar" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511000211" "doi" => "10.3265/Nefrologia.pre2011.Aug.10973" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511000211?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411000219?idApp=UINPBA000064" "url" => "/20132514/0000003100000006/v0_201502091623/X2013251411000219/v0_201502091623/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251411000235" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Sep.11014" "estado" => "S300" "fechaPublicacion" => "2011-11-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:677-82" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 6939 "formatos" => array:3 [ "EPUB" => 290 "HTML" => 5925 "PDF" => 724 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "677" "paginaFinal" => "682" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Validación de la fórmula Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) en la insuficiencia renal crónica avanzada" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11014_108_24069_en_11014t1.jpg" "Alto" => 267 "Ancho" => 600 "Tamanyo" => 122311 ] ] "descripcion" => array:1 [ "en" => "Age and anthropometric variables along with the results from glomerular filtration rates for each method used" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose Luis Teruel Briones, J.L. Teruel Briones, Antonio Gomis Couto, A. Gomis Couto, Josefa Sabater, J. Sabater, Milagros Fernández Lucas, M. Fernández Lucas, Nuria Rodríguez Mendiola, N. Rodríguez Mendiola, Juan José Villafruela, J.J. Villafruela, Carlos Quereda, C. Quereda" "autores" => array:14 [ 0 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Teruel Briones" ] 1 => array:2 [ "Iniciales" => "J.L." "apellidos" => "Teruel Briones" ] 2 => array:2 [ "nombre" => "Antonio" "apellidos" => "Gomis Couto" ] 3 => array:2 [ "Iniciales" => "A." "apellidos" => "Gomis Couto" ] 4 => array:2 [ "nombre" => "Josefa" "apellidos" => "Sabater" ] 5 => array:2 [ "Iniciales" => "J." "apellidos" => "Sabater" ] 6 => array:2 [ "nombre" => "Milagros" "apellidos" => "Fernández Lucas" ] 7 => array:2 [ "Iniciales" => "M." "apellidos" => "Fernández Lucas" ] 8 => array:2 [ "nombre" => "Nuria" "apellidos" => "Rodríguez Mendiola" ] 9 => array:2 [ "Iniciales" => "N." "apellidos" => "Rodríguez Mendiola" ] 10 => array:2 [ "nombre" => "Juan José" "apellidos" => "Villafruela" ] 11 => array:2 [ "Iniciales" => "J.J." "apellidos" => "Villafruela" ] 12 => array:2 [ "nombre" => "Carlos" "apellidos" => "Quereda" ] 13 => array:2 [ "Iniciales" => "C." "apellidos" => "Quereda" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511000238" "doi" => "10.3265/Nefrologia.pre2011.Sep.11014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511000238?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411000235?idApp=UINPBA000064" "url" => "/20132514/0000003100000006/v0_201502091623/X2013251411000235/v0_201502091623/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "Clinical application of Ultracontrol®: infusion volume and use with different dialyzers" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "683" "paginaFinal" => "689" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Marta Albalate Ramón, M. Albalate Ramón, Rafael Perez Garcia, R. Perez Garcia, Patricia de Sequera Ortiz, P. de Sequera Ortiz, Roberto Alcázar Arroyo, R. Alcázar Arroyo, Elena Corchete Prats, E. Corchete Prats, Marta Puerta Carretero, M. Puerta Carretero, Mayra Ortega Díaz, M. Ortega Díaz, Alexia Mosse, A. Mosse" "autores" => array:16 [ 0 => array:4 [ "nombre" => "Marta" "apellidos" => "Albalate Ramón" "email" => array:1 [ 0 => "malbalater@senefro.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:4 [ "Iniciales" => "M." "apellidos" => "Albalate Ramón" "email" => array:1 [ 0 => "malbalater@senefro.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 2 => array:3 [ "nombre" => "Rafael" "apellidos" => "Perez Garcia" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "Iniciales" => "R." "apellidos" => "Perez Garcia" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 4 => array:3 [ "nombre" => "Patricia" "apellidos" => "de Sequera Ortiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "Iniciales" => "P." "apellidos" => "de Sequera Ortiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 6 => array:3 [ "nombre" => "Roberto" "apellidos" => "Alcázar Arroyo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 7 => array:3 [ "Iniciales" => "R." "apellidos" => "Alcázar Arroyo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 8 => array:3 [ "nombre" => "Elena" "apellidos" => "Corchete Prats" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 9 => array:3 [ "Iniciales" => "E." "apellidos" => "Corchete Prats" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 10 => array:3 [ "nombre" => "Marta" "apellidos" => "Puerta Carretero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 11 => array:3 [ "Iniciales" => "M." "apellidos" => "Puerta Carretero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 12 => array:3 [ "nombre" => "Mayra" "apellidos" => "Ortega Díaz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 13 => array:3 [ "Iniciales" => "M." "apellidos" => "Ortega Díaz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 14 => array:3 [ "nombre" => "Alexia" "apellidos" => "Mosse" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 15 => array:3 [ "Iniciales" => "A." "apellidos" => "Mosse" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Nefrologia, Hospital Infanta Leonor, Madrid, Spain, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Infanta Leonor, Madrid, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sistema Ultracontrol® en la clínica diaria de la hemodiafiltración en línea posdilucional: volumen de infusión alcanzado y aplicabilidad con distintos dializadores" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_16025_24053_en_t1_11122.jpg" "Alto" => 128 "Ancho" => 600 "Tamanyo" => 68934 ] ] "descripcion" => array:1 [ "en" => "Technical specifications for the dialysers" ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">On-line haemodiafiltration (OL-HDF) is the most complete haemodialysis (HD) technique currently available, since it is capable of eliminating a significant amount of low, medium, and large molecular weight uraemic toxins, with direct relation to the volume of convective transport achieved.<span class="elsevierStyleSup">1</span> Traditional HD, in contrast, only eliminates small molecules and a small amount of mid-sized molecules. These cleansing benefits have a monetary cost similar to high-flux HD.</p><p class="elsevierStylePara">Recent studies have demonstrated significant improvements in the survival of patients that achieve a high number of convective transport litres per OL-HDF session. The results from the DOPPS<span class="elsevierStyleSup">2</span> observational study showed that patients on OL-HDF with more than 15l/session had a 35% higher survival rate than those with a lower rate. In 2011, two different randomised studies were presented. In the CONTRAST study,<span class="elsevierStyleSup">3</span> patients that achieved more than 20.3l/session had a higher survival rate (hazard ratio [HR]: 0.66), primarily by reducing the rate of cardiovascular mortality (HR: 0.66; <span class="elsevierStyleItalic">P</span>=.03) (HR=0.41). The Turkish HDF Study,<span class="elsevierStyleSup">4</span> which demonstrated that the convective transport volume necessary to reduce mortality was situated at a volume of infusion (Vinf) of 17.4l/session (HR: 0.54; <span class="elsevierStyleItalic">P</span>=.02). These results indicate that a Vinf value greater than 20l should be the goal for post-dilutional OL-HDF (post-OL-HDF), in the absence of an established ceiling value above which no greater value is obtained.</p><p class="elsevierStylePara">The difficulty in reaching these volumes in post-OL-HDF lies in the technical problems that haemoconcentration causes. In order to avoid this issue, a maximum ratio of 25% between the ultrafiltration flow rate (UFR) and the blood flow (Qb) rate is deemed safe, this ratio being the filtration fraction (FF), see Appendix 1 for an explanation of abbreviations. In this manner, Qb is a limiting factor for achieving the target Vinf, along with the length of the session. For example, if the actual Qb is 250ml/min for a 240min session, Vinf would be 15l, far below the goal of 20l/session. Currently, as a result of optimising Qb and the length of dialysis sessions, we have automated post-dilutional OL-HDF techniques that aid in reaching optimal convective transport values. Despite the importance of these systems, they are poorly represented in the medical literature (for example, the Fresenius<span class="elsevierStyleSup">®</span> system).<span class="elsevierStyleSup">5</span></p><p class="elsevierStylePara">Gambro<span class="elsevierStyleSup">®</span> has developed an automatic post-OL-HDF system called Ultracontrol<span class="elsevierStyleSup">®</span> (UltraC). It is based on a pressure-control system that allows for establishing the trans-membrane pressure (TMP), see Appendix 2. In the pressure-control system, TMP is constant and the infusion flow (inF) varies, generally decreasing based on the conditions of the membrane and dialyser as the dialysis session progresses. With UltraC, biosensors detect changes induced in the UFR when TMP increases (Figure 1). If the increase in UFR is significant, the change is maintained; if the increase in TMP does not favour an increase in UFR, then that pressure is the one established. In a traditional volume control system, UFR is fixed, and when this level is high, the pressure will increase, generating alarms and other problems throughout the dialysis session. As such, the fundamental advantage to an automated treatment of this type is that the post-OL-HDF produces better results without generating TMP alarms or coagulations in the dialyser.</p><p class="elsevierStylePara">In post-OL-HDF, not only must the rheological characteristics of the patient’s blood be taken into account, but also the hydraulic condition of the dialyser. These characteristics are determined by the membrane as well as the capillary and dialyser design, since these are the factors that determine the pressures maintained throughout the dialyser. As observed in the Hagen-Poiseuille formula (Appendix 3), the internal radius of the capillary (raised to the fourth power) is a determining factor, since small changes in diameter produce large changes in pressure.<span class="elsevierStyleSup">6</span> As such, the design of the dialyser is fundamental for a technique such as the UltraC to work properly, with the goal of optimising effectiveness, avoiding alarms, and facilitating the work of the nursing staff.</p><p class="elsevierStylePara">With this perspective, the objective of our study was to evaluate the UltraC as a post-OL-HDS technique. Firstly, we sought to assess the output of this unit, expressed as FF and Vinf, testing whether FF exceeded the value of 25% from the traditional system and if Vinf was higher than 20l. Secondly, we analysed how the UltraC adapts to four different dialysers.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">MATERIAL AND METHOD</span></p><p class="elsevierStylePara">We performed a prospective, observational study in two parts. In both, all patients received treatment three days per week with a mean duration of 240 minutes per session (range: 225-300 minutes)</p><p class="elsevierStylePara">The abbreviations used and their definitions are summarised in Appendix 1.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Part one. Evaluation of FF and Vinf achieved using UltraC</span></p><p class="elsevierStylePara">We examined 9 patients (7 men and 2 women, mean age of 60 [13] years, mean weight of 76 [9] kg) that had been undergoing high-flux HD treatment for more than 3 months, and that were transferred to post-OL-HDF due to medical indications. We compiled all high-flux HD sessions corresponding to the previous month and the first three months on OL-HDF. All patients had an arteriovenous fistula as a vascular access point.</p><p class="elsevierStylePara">All patients were dialysed on machines using UltraC, AK200US<span class="elsevierStyleSup">®</span>. We used the same high-flux dialyser as when patients were on HD (Polyflux210H<span class="elsevierStyleSup">®</span>), as well as the same Qb, Qd, duration of sessions, and all other dialysis characteristics. The value used for Qb was the maximum value allowed by the vascular access, without allowing pressure in the arterial line to drop below 220mm Hg.</p><p class="elsevierStylePara">During each session, the following variables were collected: Qb ml/min, CBV (l/session), UFV (l/session), maximum inF (ml/min), Vinf (l/session), UFVt (l/session), KT (l/session, ionic dialysance), TMP (mm HG), Psyst (mm Hg), and all complications derived from the technique used and coagulation that occurred during the first three months of treatment.</p><p class="elsevierStylePara">We evaluated whether FF was superior to the rate of 25% reached in the traditional volume-control technique, and if Vinf was greater than 20l.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Part two. Usefulness of UltraC using different dialysers</span></p><p class="elsevierStylePara">We evaluated 18 patients (17 men and 1 woman, mean age of 66 [75] years) that had been undergoing chronic post-OL-HDS treatment for more than 3 months on AK200US<span class="elsevierStyleSup">® </span>machines. Vascular access was achieved using a tunnelled catheter in three.</p><p class="elsevierStylePara">All patients underwent dialysis for one week using each of the different dialysers mentioned in Table 1, while maintaining all other dialysis parameters constant.</p><p class="elsevierStylePara">In each session, the following variables were measured: Psyst, TMP, Vinf, KT, the number of times the UltraC had to be withdrawn, filter coagulations, and haemoglobin and protein levels from the first week.</p><p class="elsevierStylePara">In both parts of the study, we calculated FF.</p><p class="elsevierStylePara">In all cases, the nursing staff connected the UltraC system at the start of the post-OL-HDF session, fixing the alarm systems for TMP>300 or Psyst>700mm Hg. When an alarm was triggered and the problem was not resolved, UltraC was withdrawn and the patient was transferred to a pressure-control system, which maintained the TMP at a fixed level at values that ensured a Psyst<700mm Hg and an appropriate inF.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Statistical analysis</span></p><p class="elsevierStylePara">All data were registered in a database for statistical analysis using SPSS software, version 15.0. We presented data as means and standard deviations (SD). We compared groups using paired sample analyses (paired t-test and Friedman).</p><p class="elsevierStylePara"><span class="elsevierStyleBold">RESULTS</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">Part one. Evaluation of FF and Vinf achieved using UltraC</span></p><p class="elsevierStylePara">In six patients, UltraC worked without incidents, and technical problems arose in three patients, two of which were associated with Psyst greater than 700mm Hg, and one of which was due to a TMP greater than 300mm Hg. These three patients were transferred to pressure-control systems. After this adjustment, the number of incidents per session in all nine patients was <5%.</p><p class="elsevierStylePara">The results obtained in all nine patients during the first and third months are compiled in Table 2.</p><p class="elsevierStylePara">The mean values obtained during these three months were: maximum Qb: 441 (21) ml/min (range: 350-490), CBV: 96.2 (7.7) l/session, UFV: 3.2 (0.8) l/session, Vinf: 26.3 (3.3) l/session, UFVt: 29.5 (3.4) l/session, FF: 30.6 (2.5) %, maximum TMP: 190.8mm Hg (range: 125-301), maximum Psyst: 496.5 (94.6) mm Hg. KT was 12% higher than in high-flux HD (53.8 [5.1] l/session vs 59.9 [5] l/session).</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Part two. Usefulness of UltraC using different dialysers</span></p><p class="elsevierStylePara">The mean values and ranges of Hb and proteins were, respectively, 12.1 (10.5-13.7) and 6.4 (5.9-7.3) g/dl. Maximum Psyst and TMP values appear in Table 3. Results were significantly different from those using the Elisio dialyser.</p><p class="elsevierStylePara">The UltraC had to be withdrawn in all sessions in nine, eight, four, and two patients when using the Elisio, FX 1000, FX800 and Polyflux dialysers, respectively. The dialyser that required the fewest transfers from UltraC to pressure-control systems was the Polyflux machine, followed by FX and Elisio. The mean number of sessions in which UltraC had to be withdrawn appears in Table 4.</p><p class="elsevierStylePara">Despite the switch to pressure-control, the use of all dialysers produced adequate values of Vinf and KT (Table 3), with no differences in the number of coagulations of the system. The highest values were achieved using the FX1000 dialyser, and the lowest values using the FX800.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara">Our study shows how the UltraC automated system can achieve infusion volumes of 26l and FF far greater than 25% in four hours of dialysis, with only a small number of alarms, which facilitates the application of this technique and ensures good quality of the dialysis provided. If we add to these values the UF used to maintain dry weight, the convective transport volumes reach 30l per session. With this volume, patients clearly surpass the 20l value which, according to previously cited studies, implies benefits to survival using these convective techniques.</p><p class="elsevierStylePara">UltraC periodically measures TMP and adjusts UFR, which provides an “individualised” treatment in which the dialysis machine adapts to each patient and the changes that are produced throughout the session. This adjustment produces a maximum Vinf that is superior to the value reached using traditional OL-HDF, in which a blood flow percentage is predetermined (with UltraC, we can reach an FF of almost 30% Qb).</p><p class="elsevierStylePara">The information provided by measuring Psyst is essential. The use of Psyst would cause TMP to be overestimated and would result in a reduced margin of error for this technique. Its use as an external source of information provides clues as to the changes within the dialyser throughout the session that might lead to coagulation, and allows us to anticipate events that would not be detectable with TMP alone. The measurement of Psyst favours earlier response by the nursing staff to avoid continuous alarms, coagulation of the system, and to achieve proper Vinf.</p><p class="elsevierStylePara">Only one study by Teatini et al describes the efficacy of using the UltraC system and its practical use.<span class="elsevierStyleSup">7</span> This study clearly shows the advantages of using a system such as UltraC, although the Vinf values reached are lower than we achieve in daily clinical practice, since they worked with Qb values lower than 300ml/min. In this publication, the role of Psyst in the functioning of this system is not well elaborated, with results for only one dialyser, which is an unusual situation in the daily practice of dialysis units, where various dialysers are commonly used. The results from this study, with the Vinf values reached, made us reflect on the need to take into account all the elements that we can modify to reach Vinf values greater than 20l. Although we may be using a very good technique, it might not be profitable if it does not reach the Qb values necessary for a high UFR.<span class="elsevierStyleSup">8</span></p><p class="elsevierStylePara">There is also very little in the medical literature dedicated to other automated systems such as the Fresenius<span class="elsevierStyleSup">®</span> system, which facilitates an automatic inF prescription if total protein and haematocrit values are specified. With this application, we can also achieve a greater inF, with increased convective transport while maintaining the same risk of alarms, which lends greater support to these automated systems.<span class="elsevierStyleSup">5</span></p><p class="elsevierStylePara">The second part of our study shows that although we obtained adequate KT and Vinf values in all dialysers, the number of alarms was slightly different between systems. These alarms required the transfer from UltraC to pressure-control systems, which increases the work load needed and underlines the importance of choosing the best dialyser for the technique used. The Polyflux dialyser, which is also designed by Gambro, was the design that produced the fewest number of alarms and was best adapted to the technique, as expected. In contrast, the Elisio dialyser design, with a tighter and longer fibre diameter that is optimal for a high-flux HD unit and pressure-control systems, is not well-suited for use with UltraC. As mentioned previously, the AK-200US provides an additional piece of information in the form of Psyst, and the Elisio dialyser resulted in extremely high Psyst values even in the first hour of the dialysis session, requiring a switch to pressure-control dialysis even though TMP values were not high. These Psyst alarms were a consequence of the design of the dialyser, since the Hagen-Poiseuille equation states that a smaller fibre radius induces higher pressure. In contrast, in other dialysers such as the Polyflux, Psyst continued to increase throughout the session, which indicated changing conditions within the filter and anticipated the possible partial or total coagulation of the filter. In this manner, Psyst offers information in addition to TMP, which aids in preventing complications. In other machines, such as the 5008, Psyst is integrated into the value of TMP, although this information is not provided to the user.</p><p class="elsevierStylePara">In any case, although the number of alarms was high with UltraC, forcing a switch to pressure-control systems, the efficacy of the technique was good, since we obtained adequate Vinf and KT values using all dialysers. The differences shown in these parameters in favour of the FX1000 dialyser are attributable to the fact that this dialyser has a larger surface area than the others, and the opposite is true in the smaller FX800. Clearly, the type of dialyser used is a determining factor in these techniques. Small changes in fibre diameter will influence the number of alarms produced, and small changes in surface area will produce changes in KT and Vinf that, although may seem irrelevant, involve an increase in the weekly dialysis dosage administered and, probably, will have long-term effects on survival. These findings make us reflect on the need for maximum payoff from the devices used in daily practice, which can be achieved by understanding the technical specifications and optimal use of each, since the characteristics of these systems are not solely determined by their composition.<span class="elsevierStyleSup">9</span> In this manner, although all of the dialysers used in our study were effective from a practical point of view, the dialyser best suited for use with the UltraC system is the Polyflux, and a pressure-control system should be used in the case of other types of dialysers in order to reduce the number of alarms produced.</p><p class="elsevierStylePara">One last technical aspect of OL-HDF that we would like to comment on is the loss of albumin. This loss depends on the type of dialyser,<span class="elsevierStyleSup">10,11</span> but some authors also relate this phenomenon to the application of a high TMP during the first 30 minutes of OL-HDF.<span class="elsevierStyleSup">12 </span>The UltraC system normally starts with a TMP that increases progressively during the first 30 minutes, in an attempt to avoid this complication.</p><p class="elsevierStylePara">In addition to the technical objectives of this study, making post-OL-HDF easily applicable is a fundamental step in facilitating its widespread use. As such, the number of alarms produced must be minimised in order to facilitate the work of the nursing staff. From this point of view, UltraC fulfils expectations, since the system is easily transferable to pressure-control when alarms appear, and indicates the proper TMP that needs to be set in order to achieve a proper Vinf.</p><p class="elsevierStylePara">In conclusion, UltraC is the optimal system for achieving Vinf levels greater than 20l. Dialysers with adequate purifying capabilities may not be useful for use in OL-HDF with UltraC because their flow and dynamic characteristics generate high Psyst values that impede automated use, although the final outcome may be similar. An adaptation of existing dialysers to this technique would aid nursing staff, facilitating an improved and more widespread use of OL-HDF.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara">Dr. M. Albalate has participated as a speaker in meetings organised by Gambro<span class="elsevierStyleSup">®</span> y Fresenius<span class="elsevierStyleSup">®</span>.</p><p class="elsevierStylePara">Dr. R. Pérez García and Dr. P. de Sequera have participated as speakers in meetings organised by Gambro<span class="elsevierStyleSup">®</span>, Fresenius<span class="elsevierStyleSup">®</span> and Bellco<span class="elsevierStyleSup">®</span>, and work as advisors for FMC.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Acknowledgements</span></p><p class="elsevierStylePara">We would like to thank the nursing staff at the Haemodialysis Unit of the Infanta Leonor Hospital.</p><p class="elsevierStylePara"><a href="grande/11122_16025_24053_en_t1_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_16025_24053_en_t1_11122.jpg" alt="Technical specifications for the dialysers"></img></a></p><p class="elsevierStylePara">Table 1. Technical specifications for the dialysers</p><p class="elsevierStylePara"><a href="grande/11122_108_24054_en_tabla_2_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24054_en_tabla_2_11122.gif" alt="Results from the use of OL-HDF with UltraC for three months"></img></a></p><p class="elsevierStylePara">Table 2. Results from the use of OL-HDF with UltraC for three months</p><p class="elsevierStylePara"><a href="grande/11122_108_24055_en_tabla_3_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24055_en_tabla_3_11122.gif" alt="Results from the use of UltraC with different dialysers"></img></a></p><p class="elsevierStylePara">Table 3. Results from the use of UltraC with different dialysers</p><p class="elsevierStylePara"><a href="grande/11122_108_24056_en_tabla_4_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24056_en_tabla_4_11122.gif" alt="UltraC withdrowal according to the type of dialyser used"></img></a></p><p class="elsevierStylePara">Table 4. UltraC withdrowal according to the type of dialyser used</p><p class="elsevierStylePara"><a href="grande/11122_108_24057_en_figura_1_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24057_en_figura_1_11122.jpg" alt="Schematic of the functioning of UltraC"></img></a></p><p class="elsevierStylePara">Figure 1. Schematic of the functioning of UltraC</p><p class="elsevierStylePara"><a href="grande/11122_108_24058_en_anexo_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24058_en_anexo_11122.jpg" alt="Abbreviations and definitions"></img></a></p><p class="elsevierStylePara">Abbreviations and definitions</p><p class="elsevierStylePara"><a href="grande/11122_108_24059_es_anexo_2_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24059_es_anexo_2_11122.jpg" alt="Functioning of the UltraC system"></img></a></p><p class="elsevierStylePara">Functioning of the UltraC system</p><p class="elsevierStylePara"><a href="grande/11122_108_24060_en_anexo_3_11122.jpg" class="elsevierStyleCrossRefs"><img src="11122_108_24060_en_anexo_3_11122.jpg" alt="Hagen-Poiseuille equation"></img></a></p><p class="elsevierStylePara">Hagen-Poiseuille equation</p>" "pdfFichero" => "P1-E528-S3198-A11122-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:5 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439371" "palabras" => array:1 [ 0 => "Alarmas" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439373" "palabras" => array:1 [ 0 => "Dializador" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439375" "palabras" => array:1 [ 0 => "Infusión" ] ] 3 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439377" "palabras" => array:1 [ 0 => "Ultracontrol®" ] ] 4 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec439379" "palabras" => array:1 [ 0 => "Hemodiafiltración" ] ] ] "en" => array:5 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439372" "palabras" => array:1 [ 0 => "Alarm" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439374" "palabras" => array:1 [ 0 => "Dialyzer" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439376" "palabras" => array:1 [ 0 => "Infusion" ] ] 3 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439378" "palabras" => array:1 [ 0 => "Ultracontrol®" ] ] 4 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec439380" "palabras" => array:1 [ 0 => "hemodiafiltration" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Introducción: </span>Estudios recientes indican que los beneficios en la supervivencia con hemodiafiltración en línea posdilucional (HDFOL-post) se logran si el volumen de infusión (Vinf) es superior a 20 l por sesión, cifra que no es fácil lograr por los problemas que genera la hemoconcentración. Hoy día contamos con técnicas automáticas que logran un mayor rendimiento minimizando el número de alarmas como el Ultracontrol<span class="elsevierStyleSup">® </span>(UltraC). <span class="elsevierStyleBold">Objetivo: </span>El objetivo ha sido, en una primera parte, evaluar el UltraC para conocer qué rendimiento logra (expresado como la fracción de filtración [FF] y el Vinf) y los problemas que presenta y, en una segunda parte, estudiar su funcionamiento con cuatro dializadores diferentes. <span class="elsevierStyleBold">Material y métodos: </span><span class="elsevierStyleItalic">Primera parte. </span>Nueve pacientes fueron transferidos a HDFOL-post con UltraC. Se recogieron todas las sesiones correspondientes a los tres primeros meses con HDF-OL y al mes previo en HD. <span class="elsevierStyleItalic">Segunda parte. </span>18 pacientes en tratamiento crónico con HDFOL-post fueron sometidos a diálisis una semana con cada uno de estos dializadores: FX1000, FX800, Polyflux210 y Elisio 210H. <span class="elsevierStyleBold">Resultados: </span><span class="elsevierStyleItalic">Primera parte. </span>En 3 pacientes surgieron problemas asociados a PTM y Psist inadecuadas que se resolvieron pasando a control-presión. Los valores medios obtenidos fueron: Qb máximo 441 (21) (rango 350-490) ml/min, Vinf 26,3 (3,3) l/sesión, FF 30,6% (2,5), KT 59,9 (5) l/sesión, y aumento del KT del 12% respecto al de HD. <span class="elsevierStyleItalic">Segunda parte. </span>Polyflux210 fue el dializador que precisó menos retiradas de UltraC. Las presiones recogidas tanto PTM como Psist fueron distintas y determinaron la necesidad de retirada del sistema. El KT fue adecuado. <span class="elsevierStyleBold">Conclusiones: </span><span class="elsevierStyleItalic">a) </span>El sistema UltraC alcanza FF del 30% consiguiendo Vinf adecuados con mínimas alarmas, y <span class="elsevierStyleItalic">b) </span>Dializadores con prestaciones depurativas adecuadas pueden no ser útiles para realizar HDF-OL con UltraC porque sus condiciones flujodinámicas generan alarmas que impiden la aplicación automatizada aunque el rendimento final sea semejante.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Introduction: </span>Recent studies indicate that the survival benefit with post-dilution on line hemodiafiltration (OL-HDF-post) are achieved if the infusion volume (Vinf) is greater than 20L per session, a goal that is not easily achieved due to hemoconcentration problems. Today we have automated techniques to achieve higher performance minimizing the number of alarms as Ultracontrol<span class="elsevierStyleSup">®</span> (Ultrac). The objective in the first part of study was to evaluate the UltraC performance (expressed as the filtration fraction (FF) and Vinf) and which problems it presents, and in the second part, to study its performance with four different dialyzers. <span class="elsevierStyleBold">Material and methods</span>:</span> 1st period.<span class="elsevierStyleItalic"> Nine patients were transferred to OL-HDF-post with UltraC. The first 3 months on OL-HDF all sessions were recorded and compared with hemodialysis sessions in the previous month.</span> 2nd part: <span class="elsevierStyleItalic">18 patients on chronic OL-HDF-post were dialyzed for a week with each of these dialyser: FX1000, FX800, Elisio210H and Polyflux210. <span class="elsevierStyleBold">Results</span>:</span> 1st period:<span class="elsevierStyleItalic"> In 3 patients, problems associated with inappropriate pressures emerged. In 3 patients there were problems associated with inadequate PTM and Psist that resolved changing to pressure control. Mean values ​​were: maximum Qb 441 (21) (range 350-490) ml/min, Vinf 26.3 (3.3) l/session, FF 30.6 (2.5)%, KT 59.9 (5) l/session. KT increase of 12% compared to HD.</span> 2nd part:<span class="elsevierStyleItalic"> Polyflux210 required less UltraC withdrawals than the others. Different PTM or Psist were found and determined the need for removal of the system. The KT was adequate.</span> a)<span class="elsevierStyleItalic"> The UltraC system reaches FF of 30% with minimal alarms and Vinf higher than 20 l.</span> b)<span class="elsevierStyleItalic"> Structural characteristics of dialysers can limit their use with UltraC although they managed to desirable KT and Vinf in a manual way.</span></p>" ] ] "multimedia" => array:8 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_16025_24053_en_t1_11122.jpg" "Alto" => 128 "Ancho" => 600 "Tamanyo" => 68934 ] ] "descripcion" => array:1 [ "en" => "Technical specifications for the dialysers" ] ] 1 => array:7 [ "identificador" => "tbl1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "11122_108_24054_en_tabla_2_11122.jpg" "imagenAlto" => 185 "imagenAncho" => 600 "imagenTamanyo" => 91160 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Results from the use of OL-HDF with UltraC for three months" ] ] 2 => array:7 [ "identificador" => "tbl2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "11122_108_24055_en_tabla_3_11122.jpg" "imagenAlto" => 101 "imagenAncho" => 600 "imagenTamanyo" => 66430 ] ] ] ] ] "descripcion" => array:1 [ "en" => "Results from the use of UltraC with different dialysers" ] ] 3 => array:7 [ "identificador" => "tbl3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tablaImagen" => array:1 [ 0 => array:4 [ "imagenFichero" => "11122_108_24056_en_tabla_4_11122.jpg" "imagenAlto" => 55 "imagenAncho" => 600 "imagenTamanyo" => 43433 ] ] ] ] ] "descripcion" => array:1 [ "en" => "UltraC withdrowal according to the type of dialyser used" ] ] 4 => array:8 [ "identificador" => "fig2" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_108_24057_en_figura_1_11122.jpg" "Alto" => 519 "Ancho" => 600 "Tamanyo" => 106546 ] ] "descripcion" => array:1 [ "en" => "Schematic of the functioning of UltraC" ] ] 5 => array:8 [ "identificador" => "fig3" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_108_24058_en_anexo_11122.jpg" "Alto" => 277 "Ancho" => 600 "Tamanyo" => 150377 ] ] "descripcion" => array:1 [ "en" => "Abbreviations and definitions" ] ] 6 => array:8 [ "identificador" => "fig4" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_108_24059_es_anexo_2_11122.jpg" "Alto" => 209 "Ancho" => 600 "Tamanyo" => 106971 ] ] "descripcion" => array:1 [ "en" => "Functioning of the UltraC system" ] ] 7 => array:8 [ "identificador" => "fig5" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11122_108_24060_en_anexo_3_11122.jpg" "Alto" => 185 "Ancho" => 600 "Tamanyo" => 68669 ] ] "descripcion" => array:1 [ "en" => "Hagen-Poiseuille equation" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:12 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Meert N, Eloot S, Waterloos M, Van Landschoot M, Dhondt A, Glorieux G, et al.\u{A0}Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009;24:562-70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18809977" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, et al.\u{A0}Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from DOPPS. Kidney Int 2006;69:2087-93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16641921" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Grooteman M,\u{A0}Dorpe\u{A0} R, Bots M, Penne L, Van der Weerd L, Mazairac A, et al.\u{A0}Online hemodiafiltration versus low-flux hemodialysis: effects on all-cause mortality and cardiovascular events in a randomized controlled trial. The convective transport study (CONTRAST). [LBCT3]. ERA-EDTA 2011." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ok E, Asci G, Ok E, Kircell FI, Yilmaz M, Hur E, et al. Comparison of postdilution on-line hemodiafiltration and hemodialysis (Turkish HDF Study) [LBCT2]. ERA-EDTA 2011." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Maduell F, Arias M, Garro J, Vera M, Fontseré N, Barros X, et al.\u{A0}Pauta de infusión manual automatizada: una forma práctica de prescribir la hemodiafiltración on-line posdilucional. Nefrologia 2010;30:349-53. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20514102" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ronco C, Brendolan A, Lupi A, Metry G, Levin N. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 2000;58:809-17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10916106" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Teatini U, Steckiph D, Romei G. Evaluation of a new online hemodiafiltration mode with automated pressure control of convection. Blood Purif 2011;31:259-67. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21242679" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Penne E, Van der Weerd C, Bots M, Van den Dorpel A, Grooteman M, Levesque R,\u{A0}et al.\u{A0}Patient- and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice Nephrol Dial Transplant 2009;24:3493-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ouseph R, Hutchison C, Ward R. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers. Nephrol Dial Transplant 2008;23:1704-12. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18156455" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Maduell F, Navarro V, Hernández-Jaras J, Calvo C. Comparación de dializadores en hemodiafiltración en línea. Nefrologia 2000;20:269-76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10917004" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 2004;62:21-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15267009" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kim ST, Yamamoto C, Taoka M, Takasugi M. Programmed filtation, a new method for removing large molecules and regulating albumin leakage during hemodiafiltration treatment. Am J Kidney Dis 2001;38(Supl 1):S220-S223. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11576960" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003100000006/v0_201502091623/X2013251411000227/v0_201502091623/en/main.assets" "Apartado" => array:4 [ "identificador" => "35441" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000006/v0_201502091623/X2013251411000227/v0_201502091623/en/P1-E528-S3198-A11122-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411000227?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 12 | 17 |
2024 October | 40 | 45 | 85 |
2024 September | 67 | 61 | 128 |
2024 August | 74 | 73 | 147 |
2024 July | 49 | 41 | 90 |
2024 June | 61 | 55 | 116 |
2024 May | 67 | 49 | 116 |
2024 April | 42 | 55 | 97 |
2024 March | 63 | 25 | 88 |
2024 February | 58 | 45 | 103 |
2024 January | 48 | 29 | 77 |
2023 December | 38 | 29 | 67 |
2023 November | 44 | 45 | 89 |
2023 October | 58 | 35 | 93 |
2023 September | 86 | 39 | 125 |
2023 August | 91 | 20 | 111 |
2023 July | 71 | 27 | 98 |
2023 June | 48 | 23 | 71 |
2023 May | 56 | 45 | 101 |
2023 April | 35 | 15 | 50 |
2023 March | 64 | 31 | 95 |
2023 February | 51 | 31 | 82 |
2023 January | 48 | 26 | 74 |
2022 December | 59 | 30 | 89 |
2022 November | 74 | 48 | 122 |
2022 October | 50 | 47 | 97 |
2022 September | 44 | 33 | 77 |
2022 August | 53 | 64 | 117 |
2022 July | 34 | 35 | 69 |
2022 June | 64 | 39 | 103 |
2022 May | 58 | 52 | 110 |
2022 April | 64 | 55 | 119 |
2022 March | 78 | 57 | 135 |
2022 February | 41 | 43 | 84 |
2022 January | 57 | 40 | 97 |
2021 December | 52 | 41 | 93 |
2021 November | 50 | 45 | 95 |
2021 October | 65 | 47 | 112 |
2021 September | 50 | 43 | 93 |
2021 August | 33 | 34 | 67 |
2021 July | 89 | 34 | 123 |
2021 June | 48 | 39 | 87 |
2021 May | 74 | 42 | 116 |
2021 April | 74 | 49 | 123 |
2021 March | 54 | 39 | 93 |
2021 February | 52 | 28 | 80 |
2021 January | 52 | 17 | 69 |
2020 December | 39 | 14 | 53 |
2020 November | 41 | 22 | 63 |
2020 October | 32 | 18 | 50 |
2020 September | 28 | 14 | 42 |
2020 August | 43 | 23 | 66 |
2020 July | 37 | 13 | 50 |
2020 June | 56 | 22 | 78 |
2020 May | 45 | 26 | 71 |
2020 April | 40 | 26 | 66 |
2020 March | 44 | 26 | 70 |
2020 February | 55 | 25 | 80 |
2020 January | 51 | 25 | 76 |
2019 December | 71 | 32 | 103 |
2019 November | 43 | 24 | 67 |
2019 October | 31 | 12 | 43 |
2019 September | 33 | 26 | 59 |
2019 August | 42 | 11 | 53 |
2019 July | 38 | 33 | 71 |
2019 June | 55 | 14 | 69 |
2019 May | 49 | 18 | 67 |
2019 April | 92 | 45 | 137 |
2019 March | 59 | 23 | 82 |
2019 February | 45 | 25 | 70 |
2019 January | 31 | 21 | 52 |
2018 December | 89 | 36 | 125 |
2018 November | 106 | 20 | 126 |
2018 October | 117 | 22 | 139 |
2018 September | 75 | 13 | 88 |
2018 August | 66 | 18 | 84 |
2018 July | 58 | 16 | 74 |
2018 June | 60 | 14 | 74 |
2018 May | 79 | 14 | 93 |
2018 April | 51 | 11 | 62 |
2018 March | 72 | 18 | 90 |
2018 February | 47 | 7 | 54 |
2018 January | 47 | 8 | 55 |
2017 December | 64 | 19 | 83 |
2017 November | 56 | 7 | 63 |
2017 October | 55 | 11 | 66 |
2017 September | 53 | 10 | 63 |
2017 August | 43 | 20 | 63 |
2017 July | 43 | 23 | 66 |
2017 June | 42 | 8 | 50 |
2017 May | 67 | 9 | 76 |
2017 April | 46 | 11 | 57 |
2017 March | 30 | 6 | 36 |
2017 February | 31 | 12 | 43 |
2017 January | 26 | 13 | 39 |
2016 December | 77 | 11 | 88 |
2016 November | 72 | 10 | 82 |
2016 October | 126 | 4 | 130 |
2016 September | 162 | 6 | 168 |
2016 August | 212 | 8 | 220 |
2016 July | 174 | 4 | 178 |
2016 June | 130 | 0 | 130 |
2016 May | 145 | 0 | 145 |
2016 April | 146 | 0 | 146 |
2016 March | 127 | 0 | 127 |
2016 February | 134 | 0 | 134 |
2016 January | 130 | 0 | 130 |
2015 December | 172 | 0 | 172 |
2015 November | 126 | 0 | 126 |
2015 October | 130 | 0 | 130 |
2015 September | 106 | 0 | 106 |
2015 August | 108 | 0 | 108 |
2015 July | 90 | 0 | 90 |
2015 June | 53 | 0 | 53 |
2015 May | 55 | 0 | 55 |
2015 April | 7 | 0 | 7 |